Wellâregulated placental palmitic acid (PA) and oleic acid (OA) metabolism is vital for optimal placental function and fetal development, but dysregulation occurs with gestational diabetes (GDM). We hypothesized that such dysregulation might arise from increased maternofetal glucose, leptin or insulin concentrations present in GDM, and that dysregulated PA and OA lipid metabolism could be moderated by myoâinositol, a natural polyol and potential GDM intervention. Placental explants from 21 women were incubated with stable isotopeâlabelled 13CâPA or 13CâOA for 48Â h. Explants were treated with glucose (5, 10Â mm) or leptin (13Â nm) or insulin (150Â nm) in combination with myoâinositol (0.3, 30, 60Â ÎŒm). Fortyâseven 13CâPA lipids and 37 13CâOA lipids were measured by liquid chromatographyâmass spectrometry (LCMS). Compared with controls (5Â mm glucose), glucose (10Â mm) increased 19 13CâOA lipids and nine 13CâPA lipids, but decreased 13CâOA phosphatidylethanolamine 38:5 and 13CâPA phosphatidylethanolamine 36:4. The effects of leptin and insulin were less prominent than glucose, with leptin increasing 13CâOA acylcarnitine 18:1, and insulin increasing four 13CâPA triacylglycerides. Most glucose, leptin and insulinâinduced alterations in lipids were attenuated by coâincubation with myoâinositol (30 or 60Â ÎŒm), with attenuation also occurring in all subgroups stratified by GDM status and fetal sex. However, glucoseâinduced increases in acylcarnitine were not attenuated by myoâinositol and were even exaggerated in some instances. Myoâinositol therefore appears to generally act as a moderator, suppressing the perturbation of lipid metabolic processes by glucose, leptin and insulin in placenta in vitro. Whether myoâinositol protects the fetus and pregnancy from unfavourable outcomes requires further research.
imageKey points
Incubation of placental explants with additional glucose, or to a lesser extent insulin or leptin, alters the placental production of 13Câlipids from 13Câpalmitic acid (PA) and 13Câoleic acid (OA) in vitro compared with untreated controls from the same placenta.
Coâincubation with myoâinositol attenuated most alterations induced by glucose, insulin or leptin in 13Câlipids, but did not affect alterations in 13Câacylcarnitines.
Alterations induced by glucose and leptin in 13CâPA triacylglycerides and 13CâPA phospholipids were influenced by fetal sex and gestational diabetes status, but were all still attenuated by myoâinositol coâincubation.
Insulin differently affected 13CâPA triacylglycerides and 13CâPA phospholipids depending on fetal sex, with alterations also attenuated by myoâinositol coâincubation.